RIM
CRL icon

Ranger Investment Management’s Charles River Laboratories CRL Stock Holding History

Ranger Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15M Sell
66,182
-4,533
-6% -$807K 0.95% 45
2026
Q1 		$12.2M Buy
+70,715
New +$13.1M 0.88% 50
2024
Q4 		– Sell
-19
Closed -$3.74K – 92
2024
Q3 		$3.74K Sell
19
-23
-55% -$4.78K ﹤0.01% 87
2024
Q2 		$8.68K Hold
42
– – ﹤0.01% 84
2024
Q1 		$11.4K Buy
42
+16
+62% +$3.82K ﹤0.01% 80
2023
Q4 		$6.15K Hold
26
– – ﹤0.01% 92
2023
Q3 		$5.09K Hold
26
– – ﹤0.01% 93
2023
Q2 		$5.47K Buy
26
+9
+53% +$1.79K ﹤0.01% 92
2023
Q1 		$3.43K Sell
17
-3
-15% -$680 ﹤0.01% 94
2022
Q4 		$4.36K Hold
20
– – ﹤0.01% 91
2022
Q3 		$4K Hold
20
– – ﹤0.01% 92
2022
Q2 		$4K Sell
20
-5
-20% -$1.22K ﹤0.01% 92
2022
Q1 		$7K Hold
25
– – ﹤0.01% 87
2021
Q4 		$9K Hold
25
– – ﹤0.01% 84
2021
Q3 		$10K Hold
25
– – ﹤0.01% 89
2021
Q2 		$9K Sell
25
-5
-17% -$1.67K ﹤0.01% 91
2021
Q1 		$9K Buy
30
+14
+88% +$3.89K ﹤0.01% 89
2020
Q4 		$4K Sell
16
-22
-58% -$5.24K ﹤0.01% 95
2020
Q3 		$9K Hold
38
– – ﹤0.01% 92
2020
Q2 		$7K Sell
38
-6
-14% -$958 ﹤0.01% 91
2020
Q1 		$6K Hold
44
– – ﹤0.01% 94
2019
Q4 		$7K Buy
44
+25
+132% +$3.46K ﹤0.01% 104
2019
Q3 		$3K Hold
19
– – ﹤0.01% 108
2019
Q2 		$3K Hold
19
– – ﹤0.01% 114
2019
Q1 		$3K Hold
19
– – ﹤0.01% 109
2018
Q4 		$2K Buy
+19
New +$2.38K ﹤0.01% 117

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Ranger Investment Management's CRL Position: Q2 2026 in Review

Ranger Investment Management reduced its Charles River Laboratories (CRL) stake by 6.4% in Q2 2026, selling an estimated $807K and leaving 66,182 shares worth $15M. The position accounts for 0.95% of the portfolio, ranked #45.

Ranger Investment Management first reported a position in CRL in Q4 2018 and has held it in 26 quarters since. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Ranger Investment Management held 66,182 shares of Charles River Laboratories worth $15M as of Q2 2026.
  • Ranger Investment Management sold 4,533 Charles River Laboratories shares in Q2 2026, an estimated $807K.
  • Charles River Laboratories made up 0.95% of Ranger Investment Management's portfolio in Q2 2026, its #45 holding.
  • Ranger Investment Management first reported a position in Charles River Laboratories in Q4 2018 and has held it in 26 quarters since.
  • 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Ranger Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.